The Longevity Supplement Stack: What to Take in 20…

The science of longevity supplementation has matured considerably over the past five years. Where the field once consisted largely of antioxidant hype and unverified claims, researchers now have mechanistic frameworks—mTOR signaling, NAD+ metabolism, senolytic activity, and mitophagy—that allow for more principled decisions about what to take. Still, there is a vast gap between what looks promising in mouse studies and what is proven in humans. This guide walks through the most evidence-supported longevity supplements in 2026, honest about where the data is strong and where it is not.

NAD+ Precursors: NMN and NR

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in energy metabolism and is a required substrate for sirtuin enzymes, which regulate DNA repair, inflammation, and mitochondrial function. NAD+ levels decline roughly 50% between age 20 and 60, and this decline is thought to contribute to many features of aging.

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) both raise NAD+ levels in humans—this is now well-established in pharmacokinetic studies. What remains uncertain is whether raising NAD+ through supplementation produces meaningful healthspan benefits in non-deficient humans. Animal data is compelling: NMN and NR extend healthy lifespan in mice, improve metabolic function, and protect against age-related muscle decline. Human trials are ongoing, with some showing improvements in muscle function, insulin sensitivity, and cardiovascular biomarkers in older adults.

Doses used in human trials: NR at 250–1000mg/day, NMN at 250–1200mg/day. Both appear safe. The practical debate is largely about which precursor is more effective at raising brain and tissue NAD+—NMN has a transporter (Slc12a8) for direct intestinal uptake; NR converts via different pathways. In practice, both raise blood NAD+ effectively, and the differences likely matter less than total dose.

Berberine: The Metformin Alternative

Metformin, the diabetes drug with strong epidemiological data for longevity, activates AMPK and reduces mTOR signaling—pathways associated with cellular stress resistance and lifespan extension. It is only available by prescription, which has driven interest in berberine, a plant alkaloid that activates AMPK through similar mechanisms.

Berberine has robust clinical evidence for blood glucose reduction (comparable to metformin in some trials), LDL cholesterol reduction, and improvements in insulin sensitivity. A 2024 meta-analysis covering 46 RCTs confirmed its effectiveness for metabolic syndrome markers. The longevity inference is indirect—berberine activates the same pathways as metformin, and metformin is associated with lower all-cause mortality in diabetics compared to other antidiabetic drugs—but berberine itself has no long-term human mortality data. Dose: 500mg two or three times per day with meals, as bioavailability is low and split dosing maintains steadier plasma levels.

Rapamycin-Like Approaches: Spermidine and Fisetin

Rapamycin is arguably the most reproducible life-extending intervention in mammals, working by inhibiting mTOR complex 1 and thereby inducing autophagy and reducing anabolic drive. It is not a supplement anyone should casually take—it is immunosuppressive at therapeutic doses. But the biological target it activates (or inhibits) is real and druggable.

Spermidine, a polyamine found at highest concentrations in wheat germ, activates autophagy through mechanisms that partially overlap with rapamycin-like mTOR inhibition. Observational data shows higher dietary spermidine intake associated with lower all-cause mortality. Animal data is strong. Human supplementation trials are small but show improvements in memory in older adults.

Fisetin, found in strawberries, has shown senolytic activity in Mayo Clinic research—it selectively clears senescent cells, which accumulate with age and drive chronic inflammation. Senescent cell clearance is one of the most mechanistically compelling anti-aging strategies currently under investigation. Human evidence is early-stage.

Omega-3 Fatty Acids and Vitamin D+K2

These two are unglamorous but consistently supported by both mechanism and epidemiology. EPA and DHA (marine omega-3s) reduce systemic inflammation, improve cardiovascular risk factors, and have a particularly strong protective association with cognitive aging. The VITAL trial showed omega-3 supplementation reduced cardiovascular events, and a 2022 analysis showed a 22% reduction in heart attack risk in adults not consuming fish regularly. Dose: 2–4g combined EPA+DHA daily.

Vitamin D deficiency is extraordinarily common—estimated at 40% of adults in northern latitudes—and is associated with higher all-cause mortality, impaired immune function, increased cancer risk, and worse cardiovascular outcomes. Vitamin K2 (menaquinone-7 form) directs calcium into bone rather than arterial walls, making it an important pairing. Dose: Vitamin D3 at 2000–5000 IU depending on baseline levels, K2 at 100–200mcg.

Creatine, Taurine, and Urolithin A

Creatine is no longer just a gym supplement—it has emerging evidence for cognitive function in aging, particularly under sleep deprivation or stress, and maintains muscle mass and strength in older adults, where sarcopenia is a significant driver of morbidity and mortality. 3–5g/day indefinitely.

Taurine made headlines with a 2023 paper in Science (Singh et al.) showing that taurine deficiency increases with age in multiple species, and taurine supplementation extended lifespan in mice and worms while improving bone density, immune function, and muscle function in aged animals. The biological case for taurine as a longevity intervention is now compelling, even if human trial data is not yet mature. 1–6g/day; excellent safety profile.

Urolithin A is a postbiotic produced from ellagitannins (found in pomegranate and walnuts) by gut bacteria—but only in roughly 40% of people who have the right microbiota. It activates mitophagy (clearance of damaged mitochondria) and has shown improvements in muscle function and endurance in human clinical trials. The Mitopure brand from Timeline Nutrition uses a standardized 500–1000mg dose that bypasses the conversion issue.

What Bryan Johnson Actually Takes (vs. What's Backed by Evidence)

Bryan Johnson's Blueprint protocol has brought significant public attention to longevity supplementation. He takes dozens of compounds—many at very high doses. Some are well-supported: NMN, omega-3, vitamin D+K2, creatine, spermidine, lycopene, and metformin (prescription) all have real rationale. Others—extremely high-dose lutein, astaxanthin megadosing, and various untested combinations—are experimental at best and potentially harmful through competition for absorption or unanticipated interactions at scale.

The key principle Johnson's protocol illustrates is that lifestyle interventions (sleep, exercise, caloric restriction, stress management) have larger effect sizes than any supplement. Supplementation works at the margins. For most people, the highest-ROI longevity stack is: omega-3s, vitamin D+K2, creatine, magnesium, and one NAD+ precursor—not 50 compounds taken twice daily.

Magnesium: The Overlooked Essential

Roughly 50% of Americans are deficient in magnesium, and this deficiency is associated with accelerated cellular aging through multiple mechanisms: impaired DNA repair, increased systemic inflammation, mitochondrial dysfunction, and higher cardiovascular risk. Magnesium is required for ATP synthesis (every ATP molecule exists as Mg-ATP), and inadequate levels impair hundreds of enzymatic reactions. Magnesium glycinate or malate at 200–400mg daily is a simple, inexpensive, and high-impact intervention for most people.

FAQ

Q: Is NMN or NR better for raising NAD+? Both effectively raise NAD+ levels in humans. NMN may have a slight edge for tissue-level uptake due to its dedicated intestinal transporter, but human comparative trials are limited. Either is a reasonable choice at 500mg+ daily; cost and availability often drive the decision.

Q: Should I take rapamycin for longevity? Rapamycin has strong evidence in animal models and is used by some longevity physicians at low intermittent doses (e.g., 5–6mg once weekly). It is not approved for longevity use, carries immunosuppression risk, and should only be considered under medical supervision with regular bloodwork. It is not a casual supplement.

Q: What's the single highest-impact longevity supplement? For most people who have poor dietary habits: vitamin D. For people with adequate diet and sunlight: omega-3s or creatine depending on age. NAD+ precursors are compelling but remain somewhat speculative for human longevity. No single supplement replaces sleep, resistance training, and diet quality.

Track your supplements in Optimize.

The Longevity Supplement Stack: What to Take in 2026